NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
Generex Biotechnology Corporation (GNBT) Receives Confirmation of Extension of Compliance Period From NASDAQ 11/10/2009 1:45:00 PM    More...
Generex Biotechnology Corporation (GNBT)'s Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio 11/2/2009 8:45:17 AM    More...
Generex Biotechnology Corporation (GNBT) Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice 10/30/2009 8:33:35 AM    More...
Generex Biotechnology Corporation (GNBT): Going Concern Qualification 10/21/2009 10:42:53 AM    More...
Generex Biotechnology Corporation (GNBT) Receives Purchase Order for Generex Oral-lyn(TM) for Algerian Market from Continental Pharm Laboratories 10/21/2009 10:21:55 AM    More...
Generex Biotechnology Corporation (GNBT) to Present Clincial Data at the 20th World Diabetes Congress of the International Diabetes Federation 10/19/2009 11:14:59 AM    More...
Generex Biotechnology Corporation (GNBT) Launches Generex Oral-lyn(TM) in Algeria 10/16/2009 9:01:25 AM    More...
Generex Biotechnology Corporation (GNBT) to Hold Conference Call On Thursday to Update Investors On Generex Oral-lyn(TM) and Other Corporate Activities 10/14/2009 8:30:49 AM    More...
Generex Biotechnology Corporation (GNBT) Announces FDA Price Approval for Generex Oral-lyn(TM) in the Treatment IND Program 10/14/2009 8:27:54 AM    More...
Generex Biotechnology Corporation (GNBT) Presents Abstracts At Scientific Symposium in Europe 9/30/2009 8:36:01 AM    More...
12345678910...